結構性心臟病器材市場規模、佔有率和成長分析：按產品、手術和地區分類－2026-2033年產業預測

2024 年全球結構性心臟疾病治療設備市場價值為 155 億美元，預計到 2033 年將成長至 368.5 億美元，而 2025 年為 170.7 億美元，在預測期（2026-2033 年）內複合年成長率為 10.1%。

由於系統性心臟病在人群中高發生，數百萬人受心臟疾病困擾，結構性心臟器械市場正經歷顯著成長。這些器械對於治療先天性和後天性心臟病至關重要，可透過各種經皮治療改善心臟功能並預防系統性缺陷。治療成本的預期降低有望提高其可近性。尤其隨著人口老化，經導管主動脈瓣置換術(TAVR) 等創新治療方法將變得更加經濟實惠且更具益處。這一趨勢有望降低醫療保健成本，並鼓勵患者尋求治療。反過來，這將推動對左心耳封堵術等降低中風風險的手術的需求。主要產業參與者對研發的持續投入正在推動該領域的進一步發展。

全球結構性心臟疾病治療器材市場的成長要素

全球結構性心臟器材市場的主要驅動力是心臟衰竭發生率的上升，而心臟衰竭的發生率上升主要受人口老化、缺乏運動和不健康飲食的影響。隨著主動脈瓣狹窄、二尖瓣逆流和先天性心臟疾病等疾病在老年族群的盛行率不斷增加，對有效心臟器械的需求也持續增加。這種對先進治療方案日益成長的需求正在推動心臟機械工程領域的創新，特別是經導管技術和能夠治療複雜心內疾病的器械的研發，包括各種封堵器和其他血管內治療方法。

全球結構性心臟疾病市場面臨的限制因素

由於結構性心臟器械及其微創手術的高昂成本，全球市場面臨嚴峻挑戰。在醫療資源匱乏的地區，這些成本尤其沉重，成為病患接受治療的障礙，特別是中低收入病患。因此，成本問題阻礙了市場擴張和病患接受度。此外，在某些地區，保險報銷困難加劇了這種局面，可能導致患者無法負擔必要的治療費用。這進一步抑制了這些創新心血管解決方案的市場成長。

全球結構性心臟器材市場趨勢

全球結構性心臟疾病治療器材市場正呈現顯著成長趨勢，其中經導管主動脈瓣置換術（TAVR）系統的應用日益普及尤為突出。 TAVR已成為重度主動脈瓣狹窄患者的第一線治療方法，尤其適用於不適合傳統開胸手術的患者。其微創特性正推動著結構性心臟病器材需求的成長。製造商正大力投資研發新一代TAVR解決方案，以擴大目標患者群並改善臨床療效。創新技術與不斷變化的患者需求的融合預計將進一步加速市場成長，並塑造結構性心臟病介入治療的未來。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 價值鏈分析
• 價格分析
• 案例研究
• 監理情勢
• 技術評估
• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢
• 技術分析
• 案例研究
• 價值鏈分析

全球結構性心臟器械市場規模：依產品分類。

• 心臟瓣膜裝置
  • 外科心臟瓣膜
  • 經導管心臟瓣膜
  • TAVR
  • TMVR
  • 其他經導管瓣膜
  • 閉合裝置及輸送系統
  • 環狀成形術環
  • 配件
  • 導管
  • 導管導引線
  • 鞘套
  • 其他配件
  • 其他設備

全球結構性心臟植入物市場規模：依手術方式分類。

• 置換手術
  • SAVR
  • TAVR
  • TMVR
  • 其他置換術
• 修復治療
  • LAAC
  • TMVR修復
  • TTVR
  • 瓣環成形手術
  • 其他修復照片
• 閉合技術
• 瓣環成形術

全球結構性心臟器材市場規模：依適應症分類

• 心臟瓣膜疾病
• 先天性心臟疾病
• 其他結構性心臟疾病

全球結構性心臟器材市場規模：依人口統計特徵分類

• 兒童
• 成人
• 老年人

全球結構性心臟病器材市場規模：依最終用途分類

• 醫院
• 門診手術中心
• 心臟導管檢查室
• 其他最終用途

全球結構性心臟病器材市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Abbott
• Edwards Lifesciences Corporation
• Medtronic
• Boston Scientific
• LivaNova PLC
• CryoLife
• AtriCure
• CardioKinetix
• Teleflex
• Integer Holdings Corporation
• Meril Life Sciences Pvt. Ltd.
• TTK Healthcare
• JenaValve Technology, Inc.
• Braile Biomedica
• LEPU MEDICAL TECHNOLOGY CO., LTD.
• ARTIVION, INC.
• SMT
• COOK
• Micro Interventional Devices
• WL GORE & ASSOCIATES, INC.

結論與建議

Global Structural Heart Devices Market size was valued at USD 15.5 Billion in 2024 and is poised to grow from USD 17.07 Billion in 2025 to USD 36.85 Billion by 2033, growing at a CAGR of 10.1% during the forecast period (2026-2033).

The structural heart devices market is experiencing significant growth due to the high prevalence of systemic heart diseases among the population, with millions affected by cardiac conditions. These devices are crucial in addressing both congenital and acquired heart issues through various percutaneous therapies aimed at improving heart function and preventing systemic defects. The anticipated reduction in treatment costs will likely enhance accessibility, with innovations like Transcatheter Aortic Valve Replacement becoming more affordable and beneficial as the population ages. This trend is projected to lower healthcare expenses and encourage patients to seek treatment, driving demand for procedures such as left atrial appendage closure to mitigate stroke risk. Ongoing investments in research and development by key industry players further propel advancements in the sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Structural Heart Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Structural Heart Devices Market Segments Analysis

Global Structural Heart Devices Market is segmented by Product, Procedure, and region. Based on Product, the market is segmented into Heart Valve Devices (Transcatheter Heart Valves, Surgical Heart Valves (Tissue Heart Valves, Mechanical Heart Valves)), Occluders & Delivery Systems, Annuloplasty Rings, Accessories, and Other Devices. Based on Procedure, the market is segmented into Replacement Procedures (TAVR Procedures, Savr Procedures), Repair Procedures (Closure Procedures, Annuloplasty, Valvuloplasty, TMVR Procedures). Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Structural Heart Devices Market

The global Structural Heart Devices market is significantly driven by the rising incidence of heart failure, which is largely influenced by an aging population, sedentary lifestyles, and unhealthy dietary choices. As the prevalence of conditions such as aortic stenosis, mitral regurgitation, and congenital heart defects becomes more common among older adults, the demand for effective cardiac devices continues to grow. This increasing need for advanced treatment solutions is fostering innovation in cardiac mechanical engineering, particularly in the development of transcatheter technologies and devices that can address complex intracardiac issues, including various occluders and other vascular interventions.

Restraints in the Global Structural Heart Devices Market

The global market for structural heart devices faces significant challenges due to the high costs associated with these products and their minimally invasive procedures. This expense can be particularly burdensome in regions where healthcare support is limited, creating barriers to access for patients, especially in low- to middle-income demographics. As a result, the affordability issues hinder market expansion and patient adoption. Furthermore, reimbursement difficulties in various areas exacerbate the situation, as patients may struggle to afford the necessary treatments, further stalling growth in the market for these innovative cardiovascular solutions.

Market Trends of the Global Structural Heart Devices Market

The Global Structural Heart Devices market is witnessing a significant trend marked by the growing adoption of Transcatheter Aortic Valve Replacement (TAVR) systems. As TAVR emerges as the preferred treatment for patients with severe aortic stenosis, particularly those deemed unfit for traditional open-heart surgery, its minimally invasive nature is driving increased demand for structural heart devices. Manufacturers are heavily investing in the development of next-generation TAVR solutions, aiming to broaden their patient reach and enhance clinical outcomes. This confluence of innovative technology and evolving patient needs is poised to further stimulate market growth and shape the future landscape of structural heart interventions.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape
• Technology Assessment
• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape
• Technology Analysis
• Case Studies
• Value Chain Analysis

Global Structural Heart Devices Market Size by Product & CAGR (2026-2033)

• Market Overview
• Heart Valve Devices
  • Surgical Heart Valves
  • Transcatheter Heart Valves
  • TAVR
  • TMVR
  • Other Transcatheter Valves
  • Occluders & Delivery Systems
  • Annuloplasty Rings
  • Accessories
  • Catheters
  • Guidewires
  • Sheaths
  • Other Accessories
  • Other Devices

Global Structural Heart Devices Market Size by Procedure & CAGR (2026-2033)

• Market Overview
• Replacement Procedures
  • SAVR
  • TAVR
  • TMVR
  • Other Replacement Procedures
• Repair Procedures
  • LAAC
  • TMVR Repair
  • TTVR
  • Valvuloplasty
  • Other Repair Procedures
• Closure Procedures
• Annuloplasty

Global Structural Heart Devices Market Size by Indication & CAGR (2026-2033)

• Market Overview
• Valvular Heart Diseases
• Congenital Heart Defects
• Other Structural Heart Conditions

Global Structural Heart Devices Market Size by Demographics & CAGR (2026-2033)

• Market Overview
• Pediatric
• Adult
• Geriatric

Global Structural Heart Devices Market Size by End Use & CAGR (2026-2033)

• Market Overview
• Hospitals
• Ambulatory Surgical Centers
• Cardiac Catheterization Labs
• Other End Use

Global Structural Heart Devices Market Size & CAGR (2026-2033)

• North America (Product, Procedure, Indication, Demographics, End Use)
  • US
  • Canada
• Europe (Product, Procedure, Indication, Demographics, End Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Procedure, Indication, Demographics, End Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Procedure, Indication, Demographics, End Use)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Procedure, Indication, Demographics, End Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Abbott
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Edwards Lifesciences Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LivaNova PLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CryoLife
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AtriCure
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CardioKinetix
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teleflex
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integer Holdings Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meril Life Sciences Pvt. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TTK Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• JenaValve Technology, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Braile Biomedica
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LEPU MEDICAL TECHNOLOGY CO., LTD.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ARTIVION, INC.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SMT
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• COOK
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Micro Interventional Devices
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• W. L. GORE & ASSOCIATES, INC.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations